Perfil epidemiológico da esquistossomose em comunidade periférica do município de Jequié-BA

A esquistossomose constitui-se ainda hoje como uma das parasitoses mais prevalentes do mundo e no Brasil. O município de Jequié, por sua vez, é uma das áreas endêmicas da doença, apresentando uma taxa de infecção aproximada de 1 infectado em cada 100 habitantes. Desta forma, o estudo objetiva analisar o perfil dos casos de esquistossomose em uma comunidade periférica do município de Jequié-BA, no ano de 2011, segundo características demográficas, de morbidade e de tratamento medicamentoso. Trata-se de um estudo descritivo, com abordagem quantitativa, que se baseia em dados secundários, oriundos do Programa de Controle da Esquistossomose (PCE), referentes à população da comunidade do Barro Preto, Jequié-BA, no ano de 2011. Entre o perfil de casos positivos para esquistossomose, observa-se uma maioria de indivíduos do sexo masculino, entre a faixa etária de 10 a 19 anos, com carga parasitária leve e tratados dois meses após a coleta do material fecal. Conclui-se que a falta de medidas socioeducativas, além da ausência e/ou insuficiência de saneamento básico, são determinantes para a manutenção dessa morbidade na população da comunidade em questão. Sendo assim, faz-se necessário o planejamento e execução de ações de educação em saúde, bem como a implementação de medidas sanitárias pela gestão pública municipal para o controle da esquistossomose

PERFIL EPIDEMIOLÓGICO DA ESQUISTOSSOMOSE EM COMUNIDADE PERIFÉRICA DO MUNICÍPIO DE JEQUIÉ-BAdoi: http://dx.doi.org/10.5892/ruvrd.v12i2.1463

A esquistossomose constitui-se ainda hoje como uma das parasitoses mais prevalentes do mundo e no Brasil. O município de Jequié, por sua vez, é uma das áreas endêmicas da doença, apresentando uma taxa de infecção aproximada de 1 infectado em cada 100 habitantes. Desta forma, o estudo objetiva analisar o perfil dos casos de esquistossomose em uma comunidade periférica do município de Jequié-BA, no ano de 2011, segundo características demográficas, de morbidade e de tratamento medicamentoso. Trata-se de um estudo descritivo, com abordagem quantitativa, que se baseia em dados secundários, oriundos do Programa de Controle da Esquistossomose (PCE), referentes à população da comunidade do Barro Preto, Jequié-BA, no ano de 2011. Entre o perfil de casos positivos para esquistossomose, observa-se uma maioria de indivíduos do sexo masculino, entre a faixa etária de 10 a 19 anos, com carga parasitária leve e tratados dois meses após a coleta do material fecal. Conclui-se que a falta de medidas socioeducativas, além da ausência e/ou insuficiência de saneamento básico, são determinantes para a manutenção dessa morbidade na população da comunidade em questão. Sendo assim, faz-se necessário o planejamento e execução de ações de educação em saúde, bem como a implementação de medidas sanitárias pela gestão pública municipal para o controle da esquistossomose

Electroanatomic mapping in athletes: Why and when. An expert opinion paper from the Italian society of sports cardiology

: Three-dimensional electroanatomical mapping (EAM) has the potential to identify the pathological substrate underlying ventricular arrhythmias (VAs) in different clinical settings by detecting myocardial areas with abnormally low voltages, which reflect the presence of different cardiomyopathic substrates. In athletes, the added value of EAM may be to enhance the efficacy of third-level diagnostic tests and cardiac magnetic resonance (CMR) in detecting concealed arrhythmogenic cardiomyopathies. Additional benefits of EAM in the athlete include the potential impact on disease risk stratification and the consequent implications for eligibility to competitive sports. This opinion paper of the Italian Society of Sports Cardiology aims to guide general sports medicine physicians and cardiologists on the clinical decision when to eventually perform an EAM study in the athlete, highlighting strengths and weaknesses for each cardiovascular disease at risk of sudden cardiac death during sport. The importance of early (preclinical) diagnosis to prevent the negative effects of exercise on phenotypic expression, disease progression, and worsening of the arrhythmogenic substrate is also addressed

Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease

Since 1989, SIC Sport and a FMSI, in partnership with leading Italian Cardiological Scientific Associations (ANCE, ANMCO and SIC) have produced Cardiological Guidelines for Completive Sports Eligibility for athletes with heart disease (COCIS -- 1989, 1995, 2003, 2009 and 2017). The English version of the Italian Cardiological Guidelines for Competitive Sports Eligibility for athletes with heart disease was published in 2013 in this Journal. This publication is an update with respect to the document previously published in English in 2013. It includes the principal innovations that have emerged over recent years, and is divided into five main chapters: arrhythmias, ion channel disorders, congenital heart diseases, acquired valve diseases, cardiomyopathies, myocarditis and pericarditis and ischemic heart disease. Wherever no new data have been introduced with respect to the 2013 publication, please refer to the previous version. This document is intended to complement recent European and American guidelines but an important difference should be noted. The European and American guidelines indicate good practice for people engaging in physical activity at various levels, not only at the competitive level. In contrast, the COCIS guidelines refer specifically to competitive athletes in various sports including those with high cardiovascular stress. This explains why Italian guidelines are more restrictive than European and USA ones. COCIS guidelines address 'sports doctors' who, in Italy, must certify fitness to participate in competitive sports. In Italy, this certificate is essential for participating in any competition

Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2020

Since 1989, SIC Sport and a FMSI, in partnership with leading Italian Cardiological Scientific Associations (ANCE, ANMCO and SIC) have produced Cardiological Guidelines for Completive Sports Eligibility for athletes with heart disease (COCIS -- 1989, 1995, 2003, 2009 and 2017). The English version of the Italian Cardiological Guidelines for Competitive Sports Eligibility for athletes with heart disease was published in 2013 in this Journal. This publication is an update with respect to the document previously published in English in 2013. It includes the principal innovations that have emerged over recent years, and is divided into five main chapters: arrhythmias, ion channel disorders, congenital heart diseases, acquired valve diseases, cardiomyopathies, myocarditis and pericarditis and ischemic heart disease. Wherever no new data have been introduced with respect to the 2013 publication, please refer to the previous version. This document is intended to complement recent European and American guidelines but an important difference should be noted. The European and American guidelines indicate good practice for people engaging in physical activity at various levels, not only at the competitive level. In contrast, the COCIS guidelines refer specifically to competitive athletes in various sports including those with high cardiovascular stress. This explains why Italian guidelines are more restrictive than European and USA ones. COCIS guidelines address 'sports doctors' who, in Italy, must certify fitness to participate in competitive sports. In Italy, this certificate is essential for participating in any competition

Molecular genetic testing in athletes: Why and when a position statement from the Italian society of sports cardiology

: Molecular genetic testing is an increasingly available test to support the clinical diagnosis of inherited cardiovascular diseases through identification of pathogenic gene variants and to make a preclinical genetic diagnosis among proband's family members (so-called "cascade family screening"). In athletes, the added value of molecular genetic testing is to assist in discriminating between physiological adaptive changes of the athlete's heart and inherited cardiovascular diseases, in the presence of overlapping phenotypic features such as ECG changes, imaging abnormalities or arrhythmias ("grey zone"). Additional benefits of molecular genetic testing in the athlete include the potential impact on the disease risk stratification and the implications for eligibility to competitive sports. This position statement of the Italian Society of Sports Cardiology aims to guide general sports medical physicians and sports cardiologists on clinical decision as why and when to perform a molecular genetic testing in the athlete, highlighting strengths and weaknesses for each inherited cardiovascular disease at-risk of sudden cardiac death during sport. The importance of early (preclinical) diagnosis to prevent the negative effects of exercise on phenotypic expression, disease progression and worsening of the arrhythmogenic substrate is also addressed

A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial

Multi-element interventions for first-episode psychosis (FEP) are promising, but have mostly been conducted in non-epidemiologically representative samples, thereby raising the risk of underestimating the complexities involved in treating FEP in 'real-world' services